Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Expedeon Licenses Colloidal Gold Nanoparticles to South Korean MDx Firm

Expedeon Licenses Colloidal Gold Nanoparticles to South Korean MDx Firm

Sep 11, 2018
|
staff reporter

NEW YORK (GenomeWeb) — Expedeon said today that has signed a licensing and supply agreement for its colloidal gold with South Korean diagnostics firm PaxGenBio.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

Apr
16
Featured Webinar

The Post-Vaccine COVID Testing Landscape: A Virtual Roundtable Discussion

Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

What's Popular?

In Molecular Diagnostics

  1. Bio-Rad Laboratories, Roche Enter Quality Control Partnership

  2. Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

  3. FDA Issues EUA for Adaptive Biotechnologies COVID-19 T-Cell Response Test

  4. Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

  5. Fulgent Genetics Aims to Use COVID-19 Testing Gains to Grow Clinical Sequencing Business

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.